Emmanuelle Marie Charpentier
Co-Founder & Scientific Advisory Board MemberDr. Emmanuelle Marie Charpentier Ph.D., is Co-Founder & Scientific Advisory Board Member of CRISPR Therapeutics, Inc. Dr. Charpentie is a Co-Founder of ERS Genomics and CRISPR Therapeutics. Dr. Charpentier serves as Head of the Department of Regulation in Infection Biology at the Helmholtz Centre for Infection Research in Braunschweig and Hannover Medical School. She spent five years in the US, where she held research associate positions at the Rockefeller University, New York University Langone Medical Center, the Skirball Institute of Biomolecular Medicine and St Jude Children’s Research Hospital. She headed a microbiology research group at the Max F Perutz Laboratories at the University of Vienna in Austria. Dr. Charpentier has been a Member of Scientific Advisory Board at Horizon Discovery Group plc since August 2014. She also serves as Member of Scientific Advisory Board at CRISPR Therapeutics AG and Horizon Discovery Limited. She is a Professor at the Helmholtz Centre for Infection Research and Hannover Medical School, Germany and the Laboratory for Molecular Infection Medicine at Umeå University, Sweden. Dr. Charpentier was principal co-author on a seminal publication 1 suggesting how the CRISPR-Cas9 system could be adapted from use in bacteria for broad application in mammalian genome editing. Her seminal research unveiled the key mechanisms of the CRISPR-Cas9 system, laying the foundation for the use of CRISPR-Cas9 as a highly versatile and precise gene editing tool. Dr. Charpentier is known worldwide for her work on bacterial immunity and uncovering key functional components of the bacterial CRISPR-Cas9 system. She was awarded the highly prestigious Dr. Paul Janssen Award. In 2013, she received the prestigious Alexander von Humboldt professorship, an international award for research in Germany. She studied biochemistry and microbiology at the University Pierre-and-Marie-Curie in Paris, France and she received her PhD in microbiology for her research performed at the Pasteur Institute.
Positions
- Company NameCRISPR Therapeutics AGStock CodeCRSPPositionCo-Founder & Scientific Advisory Board MemberColleagues
- SKSamarth KulkarniCEO & Chairman
- JRJames R. KasingerGeneral Counsel & Secretary
- RYRaju Yashaswi PrasadExecutive Officer
- NPNaimish PatelChief Medical Officer
- SFShaun FoyCo-Founder
- CCCraig C. MelloScientific Founder & Advisory Board Member
- MPMatthew PorteusScientific Founder & Advisory Board Member
- DGDaniel G. AndersonScientific Founder & Advisory Board Member
